Symphony Limited announced its financial results for the quarter ending June 2025, reporting a 36% year-on-year decline in consolidated revenue. The company's consolidated net profit stood at ₹42 crore for the first quarter of FY26.
Particulars | Jun'25 Qtr. | Jun'24 Qtr. | Growth (%) |
---|---|---|---|
Revenue from Operations | 251 | 393 | -36% |
EBITDA | 26 | 86 | -70% |
EBITDA Margin (%) | 10.2% | 22.3% | -12.1% |
PAT | 42 | 88 | -52% |
The Board of Directors of the Company in its meeting has approved an interim dividend of ₹1 per share (Face Value: ₹2) for FY 25-26.
Other Highlights:
- Standalone revenue declined by 39% year-on-year.
- Standalone EBITDA margin declined by 11.7%, primarily due to product mix and YoY reduced operating leverage.
- GSK China repaid ₹27.9 crore towards its inter-company loan to Symphony India, reducing outstanding loan to Symphony India, reducing outstanding loan to ₹26.1 crore.
- GSK China has successfully transferred technology know-how and nine intellectual property rights (IPRs) to IMPCO Mexico. The total transaction is valued at ~₹44 crore, with the first tranche, amounting to around ₹22 crore, already completed.
Mr. Nrupesh Shah, Managing Director (Corporate Affairs), Symphony Limited commented that Symphony Limited today announced its financial results for the quarter ending June 2025, reporting a 39% year-on-year decline in standalone revenue. This is primarily attributed to pronounced seasonal
seasonal headwinds, further accentuated by a high base of the June 2024 quarter.
Symphony is now accelerating growth across all-season and counter-seasonal categories—including tower and kitchen cooling fans, large space venti-cooling (LSV), and water heaters—by leveraging its innovation engine, powerful brand equity, and robust distribution network.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!